Article
The Prognostic Roles and Clinical Features of CD44v9 in Human Solid Cancers—A Meta-Analysis
2020-08-26
Abstract excerpt
<h4>Background: </h4> CD44 is the primary receptor for hyaluronic acid and serves as a marker for cancer stem cells. CD44v9 is one of CD44’s variants and takes part in cancer’s growth and metastasis. However, the prognostic roles and clinical features of CD44v9 in cancers remain unclear. Therefore, we conducted this meta-analysis to summarize the prognostic significance and clinical features of CD44v9 in human sol...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 0be98763-cc7e-5e44-97b9-6d4e3d21c0f4
- DOI
- 10.21203/rs.3.rs-54020/v1
